Aso, Aurelia S.

HRN: 28-60-31  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2026
CEFAZOLIN 1GM (VIAL)
02/19/2026
02/19/2026
IV
2g
Loading Dose ANST
Nonhealing Wound Right Foot
Checking Initial Appropriateness 
02/19/2026
CEFAZOLIN 1GM (VIAL)
02/19/2026
02/26/2026
IV
1g
OD
Nonhealing Wound Right Foot
Checking Initial Appropriateness 
02/19/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/19/2026
02/26/2026
IV
300mg
Q6
Nonhealing Wound Right Foot
Checking Initial Appropriateness 
02/24/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/24/2026
03/02/2026
IV
4.5g
Q8
Non Healing Wound
Checking Initial Appropriateness 
03/01/2026
LEVOFLOXACIN 500MG (TAB)
03/01/2026
03/08/2026
PO
500mg
OD
TC HAP
Checking Initial Appropriateness 
03/01/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/01/2026
04/05/2026
IV
4.5grams
Q6H
T/C HAP; Nonhealing Wound
Checking Initial Appropriateness 
03/07/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/07/2026
03/07/2026
IV
2.25g
Q8
Nonhealing Wound
Remove - Pending Acceptance
03/10/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
03/10/2026
03/17/2026
IV
80mg
Q8
CAP MR, Indected Wound Right Ankle
Checking Initial Appropriateness 
03/11/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/11/2026
03/17/2026
IV
2.25g
Q8H
Nonhealing Wound
Checking Initial Appropriateness 
03/16/2026
MUPIROCIN 2%, 15G (TUBE)
03/16/2026
03/23/2026
TOPICAL
2%
Q12
Nonhealing Wound
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: